| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 58.00K | 222.00K | 56.00K | 41.00K | 2.26M |
| Gross Profit | -1.40M | -25.00K | -1.39M | -4.02M | -5.13M | 2.28M |
| EBITDA | -2.91M | -4.53M | -3.15M | -4.77M | -6.11M | -1.84M |
| Net Income | -2.91M | -2.00M | -1.64M | -3.48M | -5.62M | -549.00K |
Balance Sheet | ||||||
| Total Assets | 18.71M | 19.54M | 21.64M | 16.21M | 19.83M | 16.92M |
| Cash, Cash Equivalents and Short-Term Investments | 257.00K | 724.00K | 336.00K | 2.06M | 6.09M | 901.00K |
| Total Debt | 1.57M | 363.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 8.62M | 8.31M | 8.91M | 3.11M | 3.08M | 1.98M |
| Stockholders Equity | 10.13M | 11.30M | 12.78M | 12.98M | 16.64M | 14.94M |
Cash Flow | ||||||
| Free Cash Flow | -3.39M | -2.61M | 2.54M | -4.99M | -2.91M | -1.84M |
| Operating Cash Flow | -1.50M | -668.00K | 5.04M | -4.88M | -2.82M | -1.79M |
| Investing Cash Flow | -440.00K | 1.00K | -8.08M | 844.00K | 415.00K | 1.06M |
| Financing Cash Flow | 1.76M | 892.00K | 1.31M | 0.00 | 7.59M | 721.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | AU$28.30M | -6.72 | -25.50% | ― | -100.00% | -182.93% | |
51 Neutral | AU$6.48M | -3.38 | -37.39% | ― | ― | -134.48% | |
46 Neutral | AU$14.72M | ― | -28.26% | ― | ― | 65.00% | |
44 Neutral | AU$13.67M | -3.62 | -213.82% | ― | ― | -32.39% | |
44 Neutral | AU$5.86M | -1.96 | -21.73% | ― | ― | 91.79% | |
43 Neutral | AU$16.84M | -2.30 | -45.16% | ― | ― | -563.16% |
ABx Group’s December 2025 quarter marked key advances across its rare earths and bauxite portfolios, underpinned by fresh funding. At its Deep Leads heavy rare earth project in northern Tasmania, ANSTO produced the first mixed rare earth carbonate from bulk material with dysprosium and terbium contents several times higher than peer products, giving ABx a significantly higher-value basket and attracting strong preliminary interest from potential separation-plant customers. Column leach tests on 26 kg samples delivered more than 80% total rare earth extraction, confirming the technical feasibility of heap leaching and giving the company flexibility in selecting lower-cost, lower-risk flowsheet options, while new exploration ground and strong drilling results at the T8 prospect further bolstered the project’s growth potential. In parallel, ABx progressed development of its ALCORE pilot plant for fluorine chemicals, fully funded and targeting completion in 2026, and advanced its near-term bauxite strategy as Good Importing International made a $2.7 million stage-one payment for 70% of the Sunrise Bauxite Project and paid an option fee for further project interests, positioning ABx for initial bauxite mining in 2026. The quarter was supported by firm commitments to raise about $6 million via a share placement, strengthening the balance sheet to fund ongoing project development and reinforcing ABx’s positioning in critical minerals and industrial materials supply chains.
The most recent analyst rating on (AU:ABX) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on ABx Group Limited stock, see the AU:ABX Stock Forecast page.
ABx Group Limited has convened an Extraordinary General Meeting for 2 March 2026, to be held entirely via Zoom webinar, with shareholders able to attend and vote virtually as if present in person. The company is leveraging permanent electronic communication relief under the Corporations Act to distribute meeting materials digitally, encouraging shareholders to lodge proxies early and submit questions in advance, underscoring an ongoing shift toward fully online corporate governance and investor engagement processes.
The most recent analyst rating on (AU:ABX) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on ABx Group Limited stock, see the AU:ABX Stock Forecast page.
ABx Group has reported highly successful column leach test results on 26-kilogram bulk samples from its Deep Leads rare earth project in northern Tasmania, with more than 80% extraction of total rare earths and over 70% extraction of key heavy magnets dysprosium and terbium. The tests, conducted by ANSTO, suggest heap leaching could outperform conventional tank leaching while offering lower capital costs and greater operational flexibility, supporting ABx’s strategy to fast-track commercial production; the company also plans to commission a second mixed rare earth carbonate sample from the leach solutions to market to potential customers that have shown strong interest in its high dysprosium and terbium content product.
The most recent analyst rating on (AU:ABX) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on ABx Group Limited stock, see the AU:ABX Stock Forecast page.
ABx Group has disclosed that it inadvertently breached ASX Listing Rule 7.1 by issuing 100,000 convertible notes and 1.2 million options on 11 June 2025 without valid shareholder approval, because the securities were issued more than three months after the March 2025 shareholder meeting that approved them, violating the timing requirement under Listing Rule 7.3.4. The ASX has confirmed that this issue of 11.2 million securities cannot be ratified retrospectively, though the company stressed that the breach does not affect the validity of its recent share and option issues and arose from an interpretive error, and ABx has reviewed its governance and compliance procedures, concluding that its existing processes and external advisory arrangements remain adequate to ensure ongoing compliance with the listing rules.
The most recent analyst rating on (AU:ABX) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on ABx Group Limited stock, see the AU:ABX Stock Forecast page.
ABx Group has reported encouraging results from a 38-hole scout drilling program at its T8 rare earth province in northern Tasmania, with one new area, designated T30, delivering intercepts of up to 3,527 ppm total rare earth oxides (excluding cerium) at shallow depths and a 7-metre mineralised interval averaging 707 ppm. The mineralisation continues to show unusually high proportions of heavy rare earths Dy and Tb across its Temple Bar and Triangle Flat tenements, reinforcing the significance of ABx’s ionic clay rare earth province and positioning the company to potentially benefit from Australia’s new Critical Minerals Strategic Reserve, which is prioritising rare earths and aims to secure domestic production for global supply chains.
The most recent analyst rating on (AU:ABX) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on ABx Group Limited stock, see the AU:ABX Stock Forecast page.
ABx Group Limited has reported significant results from preliminary rare earth column leach tests at its Deep Leads project in northern Tasmania, with extraction rates reaching a record 81% for rare earths, including high yields of highly valuable dysprosium and terbium. The results confirm the feasibility of heap leaching as a low-cost production method, potentially strengthening ABx’s market position as a producer of enriched rare earth carbonate with comparatively higher market value, marking a key step towards their goal of commencing commercial production.
ABx Group Limited has been granted a new exploration license in northern Tasmania, expanding its rare earth elements tenure by 18 km². This strategic move enhances ABx’s potential to grow its globally significant ionic rare earth project, which boasts high levels of valuable heavy rare earths. The company has also produced its first mixed rare earth carbonate product, which is priced significantly higher than peers due to its high content of dysprosium and terbium. This development positions ABx favorably in the market, with ongoing discussions with potential customers.
ABx Group Limited has received a non-refundable fee of A$300,000 from Good Importing International (GII) to extend an exclusive option to invest A$4.8 million for a 75% interest in the Taralga and Penrose Bauxite Projects in New South Wales. This strategic move strengthens ABx’s collaboration with GII, which has already invested in ABx’s Sunrise Bauxite Project in Queensland. The funds will be used for project studies, enhancing ABx’s position in the bauxite market amidst changing global dynamics, including supply disruptions in Guinea.
ABx Group Limited has announced the production of its first mixed rare earth carbonate (MREC) sample from its Deep Leads resource in Tasmania, which contains high proportions of valuable heavy rare earths like dysprosium and terbium. This positions ABx’s MREC with a basket price significantly higher than its peers, potentially enhancing its competitive edge in the market. The company will discuss this development in an investor webinar, providing stakeholders an opportunity to engage directly with management.
ABx Group Limited has issued 63,276,131 Fully Paid Ordinary Shares as part of a placement announced on November 25, 2025. This issuance was conducted without disclosure under Part 6D.2 of the Corporations Act, and the company confirms compliance with relevant provisions of the Act, indicating transparency and adherence to regulatory requirements.
ABx Group Limited has announced a significant milestone with the production of its first mixed rare earth carbonate (MREC) from the Deep Leads deposit in northern Tasmania. This MREC boasts a high content of dysprosium and terbium, making it more valuable than its peers, with a basket price up to 51% higher. The achievement positions ABx favorably in the market, as there is a high demand for MRECs with high Dy and Tb content due to supply risks. This development enhances ABx’s strategic importance in the rare earth industry, offering a compelling opportunity for prospective customers seeking high-quality, low-impurity products.
ABx Group Limited has announced an update regarding its proposed issue of securities, specifically moving some of the Tranche 1 issue to Tranche 2, pending shareholder approval. The overall amount of the capital raising remains unchanged, indicating a strategic adjustment in their financial operations without altering the total funds aimed to be raised.
ABx Group Limited’s subsidiary, ALCORE Limited, has secured full funding for its hydrogen fluoride pilot plant, with operations expected to begin in Q3 2026. This development marks a significant step in demonstrating their proprietary process and expanding into the production of fluorochemicals, potentially enhancing their industry positioning and stakeholder value.
ABx Group Limited has released an investor presentation outlining its commitment to providing materials for a cleaner future. The presentation emphasizes the company’s strategic focus on sustainability and its efforts to position itself as a key player in the environmentally-conscious mining sector.
ABx Group Limited has announced a proposed issue of securities, specifically options expiring on November 14, 2027, with a maximum of 11,245,638 securities to be issued. This move is part of a placement or other type of issue, with the proposed issue date set for January 23, 2026. The announcement indicates a strategic step for ABx Group Limited, potentially impacting its market operations and stakeholder interests by expanding its financial instruments available for trading.
ABx Group Limited has announced a proposed issue of securities, including 37,345,679 options expiring on November 14, 2027, and 74,691,358 fully paid ordinary shares. This move is part of a placement or other type of issue, with the proposed issue date set for December 2, 2025. This announcement could potentially impact ABx Group’s market position by increasing its capital base, which may be used for future growth opportunities or operational needs.
ABx Group Limited has successfully raised approximately $6 million through a share placement to sophisticated and professional investors. The funds will be used to advance the Deep Leads rare earth project in Tasmania and to construct the ALCORE pilot plant for hydrogen fluoride production. This strategic move, supported by both Australian and international investors, aims to accelerate the company’s growth and strengthen its position in the rare earths and fluorine chemical markets. The placement reflects strong investor confidence and is expected to facilitate strategic partnerships and near-term production.
ABx Group Limited, listed on the Australian Securities Exchange under the ticker ABX, has requested a trading halt on its securities pending an important announcement related to a capital raising initiative. The halt is intended to manage the company’s continuous disclosure obligations and will remain in effect until the announcement is made or until normal trading resumes on November 25, 2025. This move indicates a strategic financial maneuver by ABx Group, potentially impacting its market positioning and stakeholder interests.
ABx Group Limited announced a change in the director’s interest, specifically for Ian Levy, involving the acquisition of 781,250 fully paid ordinary shares and 781,250 options. This change was approved during the Extraordinary General Meeting held on November 13, 2025, and reflects the company’s ongoing efforts to align management interests with shareholder value.
ABx Group Limited has announced the issuance of 7,812,500 unquoted securities in the form of 2-year options exercisable at 10 cents each. This move is part of a previously announced transaction, and these securities are not intended to be quoted on the ASX, indicating a strategic financial maneuver to potentially raise capital or incentivize stakeholders.
ABx Group Limited has announced the issuance of 46,875,000 unquoted securities in the form of 2-year options exercisable at 10 cents each. This move is part of previously announced transactions and is not intended to be quoted on the ASX, potentially impacting the company’s financial structure and stakeholder interests.
ABx Group Limited has issued 1,562,500 Fully Paid Ordinary Shares to its Directors following shareholder approval at an Extraordinary General Meeting. This issuance is part of a previously announced Share Placement and was conducted without disclosure under Part 6D.2 of the Corporations Act 2001. The company confirms compliance with relevant provisions of the Corporations Act and states there is no excluded information that needs to be disclosed.
ABx Group Limited has announced the quotation of 1,562,500 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of November 17, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, benefiting stakeholders by providing more opportunities for investment.
ABx Group Limited, an Australian company listed on the ASX, announced the results of its 2025 Extraordinary General Meeting. All resolutions, including the ratification of prior share issues and the approval of issuing free attaching options under the September 2025 Placement, were carried with significant majority votes. This outcome reflects strong shareholder support for the company’s strategic initiatives, potentially enhancing its market position and operational capabilities.
ABx Group Limited has commenced drilling to expand its high-grade T8 rare earth elements mineralisation in Tasmania, following government and landholder approvals. The discovery of high-grade dysprosium and terbium, critical for modern technologies, positions ABx strategically amid China’s export restrictions on these elements, and the company is exploring low-cost, low-impact development methods.
ABx Group Limited has announced successful results from its Deep Leads ionic adsorption clay rare earth project in Tasmania, confirming the high purity of its mixed rare earth carbonate (MREC) product. The tests showed over 98% retention of rare earth elements with near-complete removal of impurities, particularly aluminium, which enhances the product’s appeal to potential customers. The company plans to deliver its first MREC product sample by the end of November, which is expected to attract strong interest from potential customers due to its high dysprosium and terbium content, low impurities, and cost-effective production process.
ABx Group Limited has reported significant progress in its heavy rare earths and clean fluorine chemical production initiatives. The company achieved high extraction rates of dysprosium and terbium under benign leach conditions, with ANSTO on track to deliver a mixed rare earth carbonate product sample by Q4 2025. Additionally, ABx secured a $3 million placement to advance its Deep Leads project and support working capital needs. The company is also advancing its bauxite projects with new investment agreements and exploration leases, positioning itself strongly in the market for rare earths and industrial chemicals.